DR. RECKEWEG R76 Herbamine Forte
- Manufacturer
- PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
- Effective date
- 2013-04-03
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:04:37
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Drosera 1X 2.5 g, Mentholum 2X 2.5 g, Convallaria majalis 3X 0.5 g, Lobelia inflata 3X 0.2 g, Stramonium 6X 0.2 g, Aconitum napellus 3X 0.1 g, Ammi visnaga 2X 0.1 g, Kali iodatum 3X 0.1 g in 10 g.
OTC - PURPOSE SECTION
Purpose
Relieves symptoms associated with asthma
INDICATIONS & USAGE SECTION
Uses
For the temporary relief of minor symptoms associated with asthma such as:
- Shortness of breath
- Tight chest
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use
- if hypersensitive to iodine.
- if hypersensitive to peppermint oil.
OTC - ASK DOCTOR SECTION
Ask a doctor before use
- in thyroid conditions.
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breastfeeding, ask a health care professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions
Adults and children ≥ 12 years 5-10 drops; children (6-11 years) 3-7 drops 1-3 times daily in a little water or undiluted or as recommended.
OTHER SAFETY INFORMATION
Other information
- Tamper resistant: Do not use if safety ring at base of cap is broken.
- Retain outer carton for full product information.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Ethanol, purified water.
OTC - QUESTIONS SECTION
Questions?
Call 1-800-361-7872 or email questions@reckeweg.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC# 53346-1376-5
Dr. Reckeweg R76 Herbamine Forte
Homeopathic preparation for the temporary relief of minor symptoms associated with asthma such as:
- Shortness of breath
- Tight chest
Manufactured by:
Dr. Reckeweg Co. GmbH
D-64625 Bensheim
Germany
1.68 fl oz
(50 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53346-1376-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b4b2-f424-e053-dadaa90a57ce | DR. RECKEWEG R76 Herbamine Forte |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53346-1376-5 | DR. RECKEWEG R76 Herbamine ForteCombination product | 50 mL in 1 BOTTLE | LIQUID | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53346-1376 | DR. RECKEWEG R76 HERBAMINE FORTE COMBINATION PRODUCT (DROSERA 1X, MENTHOLUM 2X, CONVALLARIA MAJALIS 3X, LOBELIA INFLATA 3X, STRAMONIUM 6X, ACONITUM NAPELLUS 3X, AMMI VISNAGA 2X, KALI IODATUM 3X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] | 1 | Legacy NDC, 1 package rows | 20130514_a3d04940-cb46-44de-bdeb-7a07070ef4eb.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACONITUM NAPELLUS | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| AMMI VISNAGA FRUIT | ACTIVE INGREDIENT | 3UN285QN0C | 1 | |
| CONVALLARIA MAJALIS | ACTIVE INGREDIENT | QHH4HVF5QE | 1 | |
| DATURA STRAMONIUM | ACTIVE INGREDIENT | G6W4F0V8Z3 | 1 | |
| DROSERA ROTUNDIFOLIA | ACTIVE INGREDIENT | QR44N9XPJQ | 1 | |
| LOBELIA INFLATA | ACTIVE INGREDIENT | 9PP1T3TC5U | 1 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| POTASSIUM IODIDE | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| ACONITUM NAPELLUS | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| AMMI VISNAGA FRUIT | ACTIVE MOIETY | 3UN285QN0C | 1 | |
| CONVALLARIA MAJALIS | ACTIVE MOIETY | QHH4HVF5QE | 1 | |
| DATURA STRAMONIUM | ACTIVE MOIETY | G6W4F0V8Z3 | 1 | |
| DROSERA ROTUNDIFOLIA | ACTIVE MOIETY | QR44N9XPJQ | 1 | |
| IODIDE ION | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| LOBELIA INFLATA | ACTIVE MOIETY | 9PP1T3TC5U | 1 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- DR. RECKEWEG R76 Herbamine Forte Combination product
- Drosera 1X, Mentholum 2X, Convallaria majalis 3X, Lobelia inflata 3X, Stramonium 6X, Aconitum napellus 3X, Ammi visnaga 2X, Kali iodatum 3X
- DROSERA ROTUNDIFOLIA
- MENTHOL
- CONVALLARIA MAJALIS
- LOBELIA INFLATA
- DATURA STRAMONIUM
- ACONITUM NAPELLUS
- AMMI VISNAGA FRUIT
- POTASSIUM IODIDE
- IODIDE ION
- ALCOHOL
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53346-1376 | 53346-1376-5 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DROSERA ROTUNDIFOLIA | QR44N9XPJQ | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
| CONVALLARIA MAJALIS | QHH4HVF5QE | ACTIB |
| LOBELIA INFLATA | 9PP1T3TC5U | ACTIB |
| DATURA STRAMONIUM | G6W4F0V8Z3 | ACTIB |
| ACONITUM NAPELLUS | U0NQ8555JD | ACTIB |
| AMMI VISNAGA FRUIT | 3UN285QN0C | ACTIB |
| POTASSIUM IODIDE | 1C4QK22F9J | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a8bc3f20-8639-40d3-8ff1-e3ddc0a0165a | a3d04940-cb46-44de-bdeb-7a07070ef4eb | 2013-04-03 | Warnings | a8bc3f20-8639-40d3-8ff1-e3ddc0a0165a a3d04940-cb46-44de-bdeb-7a07070ef4eb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
